{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T13:37:22Z","timestamp":1784122642079,"version":"3.55.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1016\/j.vaccine.2015.12.032","type":"journal-article","created":{"date-parts":[[2015,12,22]],"date-time":"2015-12-22T23:01:20Z","timestamp":1450825280000},"page":"995-1001","source":"Crossref","is-referenced-by-count":32,"title":["Workshop report: Schistosomiasis vaccine clinical development and product characteristics"],"prefix":"10.1016","volume":"34","author":[{"given":"Annie X.","family":"Mo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel G.","family":"Colley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1 (Jan)","key":"10.1016\/j.vaccine.2015.12.032_bib0125","doi-asserted-by":"crossref","first-page":"54","DOI":"10.4269\/ajtmh.13-0467","article-title":"Schistosomiasis elimination strategies and potential role of a vaccine in achieving global health goals","volume":"90","author":"Mo","year":"2014","journal-title":"Am J Trop Med Hyg"},{"issue":"11 (Nov)","key":"10.1016\/j.vaccine.2015.12.032_bib0130","first-page":"A47","article-title":"Human behaviour, cost-effectiveness analysis and research and development priorities: the case of a schistosomiasis vaccine","volume":"2","author":"Evans","year":"1997","journal-title":"Trop Med Int Health"},{"issue":"13 (Nov)","key":"10.1016\/j.vaccine.2015.12.032_bib0135","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1017\/S0031182010000867","article-title":"A new approach to modelling schistosomiasis transmission based on stratified worm burden","volume":"137","author":"Gurarie","year":"2010","journal-title":"Parasitology"},{"issue":"3 (Mar)","key":"10.1016\/j.vaccine.2015.12.032_bib0140","doi-asserted-by":"crossref","first-page":"417","DOI":"10.4269\/ajtmh.2012.10-0415","article-title":"The economic value of a visceral leishmaniasis vaccine in Bihar state, India","volume":"86","author":"Lee","year":"2012","journal-title":"Am J Trop Med Hyg"},{"issue":"9 (Sep)","key":"10.1016\/j.vaccine.2015.12.032_bib0145","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.4161\/hv.20966","article-title":"Modeling the economic value of a Chagas\u2019 disease therapeutic vaccine","volume":"8","author":"Lee","year":"2012","journal-title":"Hum Vaccin Immunother"},{"issue":"7 (Jul)","key":"10.1016\/j.vaccine.2015.12.032_bib0150","doi-asserted-by":"crossref","first-page":"e1704","DOI":"10.1371\/journal.pntd.0001704","article-title":"Safety and immunogenicity of rSh28GST antigen in humans: phase 1 randomized clinical study of a vaccine candidate against urinary schistosomiasis","volume":"6","author":"Riveau","year":"2012","journal-title":"PLoS Negl Trop Dis"},{"issue":"9 (Nov)","key":"10.1016\/j.vaccine.2015.12.032_bib0155","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1093\/infdis\/jir545","article-title":"Preclinical prophylactic efficacy testing of Sm-p80-based vaccine in a nonhuman primate model of Schistosoma mansoni infection and immunoglobulin G and E responses to Sm-p80 in human serum samples from an area where schistosomiasis is endemic","volume":"204","author":"Ahmad","year":"2011","journal-title":"J Infect Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2015.12.032_bib0160","doi-asserted-by":"crossref","first-page":"e1564","DOI":"10.1371\/journal.pntd.0001564","article-title":"Enhanced protective efficacy of a chimeric form of the schistosomiasis vaccine antigen Sm-TSP-2","volume":"6","author":"Pearson","year":"2012","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2015.12.032_bib0165","article-title":"Schistosomiasis vaccine candidate Sm14\/GLA-SE: phase 1 safety and immunogenicity clinical trial in healthy, male adults","author":"Santini-Oliveira","year":"2015","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.vaccine.2015.12.032_bib0170","doi-asserted-by":"crossref","first-page":"e1922","DOI":"10.1371\/journal.pntd.0001922","article-title":"Differential anti-glycan antibody responses in Schistosoma mansoni-infected children and adults studied by shotgun glycan microarray","volume":"6","author":"van","year":"2012","journal-title":"PLoS Negl Trop Dis"},{"issue":"11 (Mar 5)","key":"10.1016\/j.vaccine.2015.12.032_bib0175","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1016\/j.vaccine.2013.12.057","article-title":"Cross-species protection: Schistosoma mansoni Sm-p80 vaccine confers protection against Schistosoma haematobium in hamsters and baboons","volume":"32","author":"Karmakar","year":"2014","journal-title":"Vaccine"},{"issue":"12 (Feb 23)","key":"10.1016\/j.vaccine.2015.12.032_bib0180","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1093\/infdis\/jiu031","article-title":"Use of an Sm-p80-based therapeutic vaccine to kill established adult schistosome parasites in chronically infected baboons","volume":"209","author":"Karmakar","year":"2014","journal-title":"J Infect Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2015.12.032_bib0185","doi-asserted-by":"crossref","first-page":"e0120792","DOI":"10.1371\/journal.pone.0120792","article-title":"Enhancement of protective efficacy through adenoviral vectored vaccine priming and protein boosting strategy encoding triosephosphate isomerase (SjTPI) against Schistosoma japonicum in mice","volume":"10","author":"Dai","year":"2015","journal-title":"PLoS One"},{"issue":"Pt 1 (Jan)","key":"10.1016\/j.vaccine.2015.12.032_bib0190","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1017\/S0031182005008644","article-title":"Schistosoma japonicum triose-phosphate isomerase plasmid DNA vaccine protects pigs against challenge infection","volume":"132","author":"Zhu","year":"2006","journal-title":"Parasitology"},{"key":"10.1016\/j.vaccine.2015.12.032_bib0195","doi-asserted-by":"crossref","first-page":"347","DOI":"10.3389\/fimmu.2015.00347","article-title":"Development of paramyosin as a vaccine candidate for schistosomiasis","volume":"6","author":"Jiz","year":"2015","journal-title":"Front Immunol"},{"issue":"5 (May 11)","key":"10.1016\/j.vaccine.2015.12.032_bib0200","doi-asserted-by":"crossref","first-page":"e0003730","DOI":"10.1371\/journal.pntd.0003730","article-title":"Suppression of the insulin receptors in adult Schistosoma japonicum impacts on parasite growth and development: further evidence of vaccine potential","volume":"9","author":"You","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"issue":"1 (Jul)","key":"10.1016\/j.vaccine.2015.12.032_bib0205","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.jaci.2012.04.027","article-title":"Generalized urticaria induced by the Na-ASP-2 hookworm vaccine: implications for the development of vaccines against helminths","volume":"130","author":"Diemert","year":"2012","journal-title":"J Allergy Clin Immunol"},{"issue":"Suppl 2 (Apr 18)","key":"10.1016\/j.vaccine.2015.12.032_bib0210","doi-asserted-by":"crossref","first-page":"B227","DOI":"10.1016\/j.vaccine.2012.11.034","article-title":"The human hookworm vaccine","volume":"31","author":"Hotez","year":"2013","journal-title":"Vaccine"},{"issue":"5 (May)","key":"10.1016\/j.vaccine.2015.12.032_bib0215","doi-asserted-by":"crossref","first-page":"e0003752","DOI":"10.1371\/journal.pntd.0003752","article-title":"Sensitivity and specificity of a urine circulating anodic antigen test for the diagnosis of Schistosoma haematobium in low endemic settings","volume":"9","author":"Knopp","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"issue":"6 (May)","key":"10.1016\/j.vaccine.2015.12.032_bib0220","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.ijpara.2014.02.004","article-title":"Human IgE responses to different splice variants of Schistosoma mansoni tropomyosin: associations with immunity","volume":"44","author":"Silas","year":"2014","journal-title":"Int J Parasitol"},{"issue":"6306 (Jan 17)","key":"10.1016\/j.vaccine.2015.12.032_bib0225","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/349243a0","article-title":"Human IgE, IgG4 and resistance to reinfection with Schistosoma haematobium","volume":"349","author":"Hagan","year":"1991","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2015.12.032_bib0230","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.exppara.2015.03.012","article-title":"Immuno-evasive tactics by schistosomes identify an effective allergy preventative","volume":"153","author":"Griffith","year":"2015","journal-title":"Exp Parasitol"},{"issue":"12 (Aug)","key":"10.1016\/j.vaccine.2015.12.032_bib0235","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/0264-410X(95)00083-D","article-title":"Human schistosomiasis: potential consequences of vaccination","volume":"13","author":"Woolhouse","year":"1995","journal-title":"Vaccine"},{"issue":"9 (Aug)","key":"10.1016\/j.vaccine.2015.12.032_bib0240","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.ijpara.2014.05.005","article-title":"A multi-component integrated approach for the elimination of schistosomiasis in the People's Republic of China: design and baseline results of a 4-year cluster-randomised intervention trial","volume":"44","author":"Gray","year":"2014","journal-title":"Int J Parasitol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X1501823X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X1501823X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,16]],"date-time":"2018-09-16T17:52:13Z","timestamp":1537120333000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X1501823X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2]]},"references-count":24,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["S0264410X1501823X"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.12.032","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,2]]}}}